Qube Research & Technologies LTD Invitae Corp Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $281,258 - $436,619	-267,865 Reduced 91.9%	23,614 $26,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.73 $221,462 - $503,826	-184,552 Reduced 38.77%	291,479 $393,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $814,013 - $1.72 Million	476,031 New	476,031 $885,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $727,776 - $3.08 Million	-341,679 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$6.28 - $15.59 $2.15 Million - $5.33 Million	341,679 New	341,679 $2.72 Million
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $777,240 - $1.34 Million	-23,510 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $373,153 - $547,940	9,546 Added 68.36%	23,510 $983,000
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $396,996 - $623,771	13,964 New	13,964 $605,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.